Financial Analysis: Compass Pathways Plc ADR (CMPS)’s Ratios Unveil Key Insights

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Compass Pathways Plc ADR’s stock clocked out at $4.67, up 14.04% from its previous closing price of $4.09. In other words, the price has increased by $14.04 from its previous closing price. On the day, 1.38 million shares were traded. CMPS stock price reached its highest trading level at $4.675 during the session, while it also had its lowest trading level at $4.1106.

Ratios:

To gain a deeper understanding of CMPS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.91 and its Current Ratio is at 8.91. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.15.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on July 23, 2024, initiated with a Outperform rating and assigned the stock a target price of $23.

On April 01, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $30.

On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $16.Deutsche Bank initiated its Buy rating on December 12, 2023, with a $16 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 26 ’24 when ATAI Life Sciences N.V. sold 2,660,000 shares for $6.05 per share. The transaction valued at 16,093,000 led to the insider holds 6,905,774 shares of the business.

Malievskaia Ekaterina sold 8,900 shares of CMPS for $70,379 on May 21 ’24. The 10% Owner now owns 3,931,687 shares after completing the transaction at $7.91 per share. On May 21 ’24, another insider, Malievskaia Ekaterina, who serves as the 10% Owner of the company, sold 8,900 shares for $7.91 each. As a result, the insider received 70,379 and left with 3,929,413 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMPS now has a Market Capitalization of 319525152 and an Enterprise Value of 145125216.

Stock Price History:

Over the past 52 weeks, CMPS has reached a high of $12.75, while it has fallen to a 52-week low of $4.00. The 50-Day Moving Average of the stock is -13.85%, while the 200-Day Moving Average is calculated to be -36.16%.

Shares Statistics:

It appears that CMPS traded 832.44K shares on average per day over the past three months and 703970 shares per day over the past ten days. A total of 68.41M shares are outstanding, with a floating share count of 62.67M. Insiders hold about 8.40% of the company’s shares, while institutions hold 39.55% stake in the company. Shares short for CMPS as of 1731628800 were 4173097 with a Short Ratio of 5.01, compared to 1728950400 on 5807649. Therefore, it implies a Short% of Shares Outstanding of 4173097 and a Short% of Float of 7.290000000000001.

Most Popular